FRI651 Usage Of Modern Sulphonylureas And Metformin Fixed Dose Combination (fdc) In Type 2 Diabetes Mellitus (t2dm) Patients With Established Complications

Disclosure: A. M: None. D. Prasad: None. D. Birla: None. L. Nagendra: None. B. Bansal: None. S. Shaikh: None. Aim: To evaluate the usage of sulphonylureas (SUs) and metformin fixed dose combinations (FDC) in type 2 diabetes mellitus (T2DM) patients with established complications Background: Patients...

Descripción completa

Detalles Bibliográficos
Autores principales: M, Aushili, Prasad, Dr Ashish, Nagendra, Lakshmi, Sinha, Binayak, Bansal, Beena, Shaikh, Shehla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Diabetes And Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555671/
http://dx.doi.org/10.1210/jendso/bvad114.870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555671/
http://dx.doi.org/10.1210/jendso/bvad114.870

Ejemplares similares